325 related articles for article (PubMed ID: 33128920)
1. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
2. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F
Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.
Liu T; Hou Y; Dai TJ; Yan CZ
Chin Med J (Engl); 2017 Sep; 130(17):2101-2106. PubMed ID: 28836555
[TBL] [Abstract][Full Text] [Related]
6. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
[TBL] [Abstract][Full Text] [Related]
7. The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.
Pleštilová L; Mann H; Andrés Cerezo L; Pecha O; Vencovský J; Šenolt L
Arthritis Res Ther; 2014 Oct; 16(5):468. PubMed ID: 25359220
[TBL] [Abstract][Full Text] [Related]
8. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
9. Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Iannone F
Reumatismo; 2014 Nov; 66(3):215-23. PubMed ID: 25376956
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of protein-bound 3-nitrotyrosine in inflammatory myopathies.
Zámecník J; Vytásek R; Vencovský J; Vilím V
Cesk Patol; 2011 Apr; 47(2):62-5. PubMed ID: 21598762
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis.
Andrés Cerezo L; Hulejová H; Šumová B; Kropáčková T; Kryštůfková O; Klein M; Mann HF; Zámečník J; Pecha O; Pavelka K; Vencovský J; Šenolt L
Cytokine; 2019 Apr; 116():13-20. PubMed ID: 30684913
[TBL] [Abstract][Full Text] [Related]
12. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
13. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
14. Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.
Fernandez C; Bardin N; De Paula AM; Salort-Campana E; Benyamine A; Franques J; Schleinitz N; Weiller PJ; Pouget J; Pellissier JF; Figarella-Branger D
Medicine (Baltimore); 2013 Jan; 92(1):15-24. PubMed ID: 23269233
[TBL] [Abstract][Full Text] [Related]
15. Resistin in idiopathic inflammatory myopathies.
Filková M; Hulejová H; Kuncová K; Pleštilová L; Cerezo LA; Mann H; Klein M; Zámečník J; Gay S; Vencovský J; Senolt L
Arthritis Res Ther; 2012 May; 14(3):R111. PubMed ID: 22577940
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
18. Local expression of cytokines in idiopathic inflammatory myopathies.
Lepidi H; Frances V; Figarella-Branger D; Bartoli C; Machado-Baeta A; Pellissier JF
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):73-9. PubMed ID: 9549732
[TBL] [Abstract][Full Text] [Related]
19. Low serum levels of vitamin D in idiopathic inflammatory myopathies.
Azali P; Barbasso Helmers S; Kockum I; Olsson T; Alfredsson L; Charles PJ; Piehl Aulin K; Lundberg IE
Ann Rheum Dis; 2013 Apr; 72(4):512-6. PubMed ID: 22993226
[TBL] [Abstract][Full Text] [Related]
20. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
